Cancer Research UK to invest £45 million in new trials

Cancer Research UK is to invest £45 million in what it has described as being among its "largest investments in clinical research to date".

The funding will support clinical trials aimed at testing an array of medical interventions, with work taking place through clinical trial units (CTUs) in Cardiff, Birmingham, Glasgow, Southampton, Leeds and London. Trials in the capital will take place at The Institute of Cancer Research, London, University College London and Queen Mary University of London.

Cancer Research UK’s children’s cancer expert Professor Pamela Kearns, who directs the CTU in Birmingham, said trials are vital in helping establish the effectiveness of adult treatments when applied to children. 

She added: “One question this trial is trying to answer is if a drug called bevacizumab can help treat their neuroblastoma. Bevacizumab is a type of biological therapy called a monoclonal antibody that targets the tumour’s blood supply. 

"Doctors already treat adult cancers with this drug and we want to see if it works for children with neuroblastoma."

With over 20 years of experience within the Science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today. 

Image: iStock